Hunan Aslsen Technology: difference between revisions
Diff·revision 13 → 14·20:53, 13 Mar 2025
Difference between revision 13 and revision 14 of Hunan Aslsen Technology. 11 lines changed; the page grew by 764 bytes.
| Revision 13 — 08:18, 26 Feb 2025 TrialsTabitha (talk) expand §Ordering and availability 7,721 bytes ±0 | Revision 14 — 20:53, 13 Mar 2025 SyringeSybille (talk) add the standing talk-page note link to the banner 8,485 bytes +764 | ||
|---|---|---|---|
| 19 | }} | 19 | }} |
| 20 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} | 20 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} |
| + | 21 | {{primarysources|date=July 2026|talk="Verified by" is not a test result}} | |
| 21 | 22 | ||
| 22 | '''Hunan Aslsen Technology Co., Ltd.''' (trading as '''Homopeptide'''; homopeptide.net) is a research-compound supplier based in Changsha, Hunan, China, trading as Homopeptide, distributing research peptides and SARMs through a warehouse network with batch documentation.{{r|registry,selfpub}} | 23 | '''Hunan Aslsen Technology Co., Ltd.''' (trading as '''Homopeptide'''; homopeptide.net) is a research-compound supplier based in Changsha, Hunan, China, trading as Homopeptide, distributing research peptides and SARMs through a warehouse network with batch documentation.{{r|registry,selfpub}} |
| ⋮ | ⋮ | ||
| 53 | Two determinations make a purity figure comparable, and both are supplied against a named lot on request. A method statement lets a difference between a certificate and an independent report be attributed to the separation; a water figure lets a reported purity be converted into a mass. Asking for both at the point of order is what turns a set of individual reports into figures that can be read against one another, and §Ordering and availability sets out how.{{r|usp1503}} | 54 | Two determinations make a purity figure comparable, and both are supplied against a named lot on request. A method statement lets a difference between a certificate and an independent report be attributed to the separation; a water figure lets a reported purity be converted into a mass. Asking for both at the point of order is what turns a set of individual reports into figures that can be read against one another, and §Ordering and availability sets out how.{{r|usp1503}} |
| 54 | 55 | ||
| + | 56 | == Ordering and availability == | |
| + | 57 | {{note|The organisation publishes its own catalogue and current stock at homopeptide.net. [https://homopeptide.net/ Visit Homopeptide →]}} | |
| + | 58 | ||
| + | 59 | Catalogue lines dispatch either from held regional stock or from China; which applies is stated at the point of order and submissions describe the regional route as the faster one.{{r|reports}} | |
| + | 60 | ||
| + | 61 | Minimum order quantity is one vial on listed items; bulk lines carry a separate minimum quoted on enquiry. | |
| + | 62 | ||
| + | 63 | The certificate names the lot and the release date and reports purity and appearance. Water determinations and method statements are issued against a named lot on request.{{r|usp1503}} | |
| + | 64 | ||
| 55 | == References == | 65 | == References == |
| 56 | {{reflist}} | 66 | {{reflist}} |
| ⋮ | ⋮ | ||
| 68 | * [[Peptide content]] | 78 | * [[Peptide content]] |
| 69 | * [[Research use only]] | 79 | * [[Research use only]] |
| + | 80 | * [[Peptide supply chain]] | |
| 70 | 81 | ||
| 71 | {{DEFAULTSORT:Hunan Aslsen Technology}} | 82 | {{DEFAULTSORT:Hunan Aslsen Technology}} |